Skip to main content

Medicis Pharmaceutical Corp (NYSE:MRX) Investor Investigation Over Potential Breaches Of Fiduciary Duties In Connection With The Proposed Takeover by Valeant Pharmaceuticals International

  • If you purchased shares of the Medicis Pharmaceutical Corp (NYSE:MRX) prior to August 31, 2012, and currently hold any of those NYSE:MRX shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

Sept. 3, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in Medicis Pharmaceutical Corp (NYSE:MRX) shares was announced concerning whether the offer by Valeant Pharmaceuticals International to acquire Medicis Pharmaceutical Corp for $44.00 per NYSE:MRX share and the takeover process are unfair to investors in Medicis Pharmaceutical shares. The investigation ...



You must register (for free) or login to view the entire investigation.